European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Community Register of medicinal products
Community register of veterinary medicinal products |
AUTHORISED |
Product information |
| Invented name: | Ypozane
|
| Auth. number : | EU/2/06/068 |
| INN : | Osaterone acetate |
| ATC: | QG - Genito-urinary system and sex hormones QG04 - Urologicals QG04C - Drugs used in benign prostatic hypertrophy QG04CX - Other estrogens QG04CX - Other estrogens (See WHO ATCvet Index) |
| Indication: | Treatment of benign prostatic hypertrophy (BPH) in male dogs |
| Marketing Authorisation Holder: | VIRBAC S.A.
1ère Avenue – 2065 m – L.I.D., F-06516 Carros CEDEX, France |
EPAR and active package presentations
Package presentations
|
The section of the Community Register "Package presentations" will no longer be updated as from 2 November 2012.
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information". Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register. |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 15/01/2007 | Centralised - Authorisation | EMEA/V/C/112 | (2007)117 of 11/01/2007 | |||
| 21/12/2011 | Centralised - Renewal | EMEA/V/C/112/R/1 | (2011)9952 of 19/12/2011 |